“Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study”. 2018. SKIN The Journal of Cutaneous Medicine 2 (December): S86. https://doi.org/10.25251/skin.2.supp.87.